Global Epigenetics Market Overview:
The latest report by IMARC Group, titled “Epigenetics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” offers a comprehensive analysis of the industry, which comprises insights on the epigenetics market share. The report also includes competitor and regional analysis, and contemporary advancements in the market. The global epigenetics market size reached US$ 1.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2027, exhibiting a growth rate (CAGR) of 16.7% during 2022-2027. Epigenetics refers to the study of variations in cellular and physiological traits without any change in the deoxyribonucleic acid (DNA) sequence. It identifies past exposure to various physicochemical and psychosocial factors, such as toxic pollutants, cosmetics, familial stress, and social adversity. Epigenetic changes include chromatin remodeling and methylation, acetylation, phosphorylation, and ubiquitylation of DNA and histone proteins. It involves the use of various enzymes and instruments, including spectrometers, sequencers, reagents, and kits. Epigenetics is widely used in diagnosing, prognosis, and treating cancer, metabolic disorders, autoimmune disease, allergy, infertility, infections, respiratory illnesses, and cognitive dysfunction. As a result, they are utilized in oncology and non-oncology applications to provide predictive information about an individual’s disease risk profile and response to specific treatments.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviors of the consumers globally–our estimates about the latest market trends and forecast values after considering the impact of this pandemic.
Request Free Sample Report: https://www.imarcgroup.com/epigenetics-market/requestsample
Global Epigenetics Market Trends:
The rising incidence of cancer across the globe is one of the primary factors driving the market growth. Epigenetics is widely used for the diagnosis, treatment, and prevention of hematological malignancies, adult myeloid leukemia (AML), myelodysplastic syndrome (MDS), cutaneous T-cell lymphoma (CTCL), myeloma, and various other forms of cancer, as it provides markers to detect cancer cells and destroy solid tumors. In addition to this, the adoption of epigenetic drugs in combination therapy, including chemotherapy, radiation, and immunotherapy, to increase the effectiveness of treatment, improve the efficacy of drugs, and enhance the anticancer effect is acting as another growth-inducing factor. Furthermore, the widespread utilization of epigenetics in the agriculture industry to accelerate crop breeding, improve production yield, and engineer plants that harbor advantageous traits to fight climate change effectively is providing an impetus to the market growth. Additionally, the integration of epigenetics with personalized medicines to develop highly-specific biomarkers that provide accurate disease prognosis, allow treatment monitoring, optimize outcomes, reduce adverse side-effects, encourage optimum use of healthcare resources, and aid in disease management is positively influencing the market growth. Moreover, the recent development of epigenetic magnetic resonance imaging (MRI), a non-invasive technique for imaging DNA methylation in the brain, which offers potential applications for studying brain functions, behavior, and diseases, is favoring the market growth. Other factors, including increasing investments by several governments in research and development (R&D) activities to improve the quality of care and introduce new technologies, the surge in genome mapping programs, and significant improvements in healthcare infrastructure, are anticipated to drive market growth.
Global Epigenetics Market 2022-2027 Analysis and Segmentation
Competitive Landscape with Key Players:
- Abcam plc
- Active Motif Inc.
- Agilent Technologies Inc
- Diagenode Diagnostics (Hologic Inc)
- Illumina Inc.
- Merck KGaA
- PerkinElmer Inc.
- Roche Holding AG
- Thermo Fisher Scientific Inc
- Zymo Research Corporation
The competitive landscape of the industry has also been examined, with some of the key players being Abcam plc, Active Motif Inc., Agilent Technologies Inc., Diagenode Diagnostics (Hologic Inc), Illumina Inc., Merck KGaA, PerkinElmer Inc., Roche Holding AG, Thermo Fisher Scientific Inc. and Zymo Research Corporation.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global epigenetics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, technology and application.
Breakup by Product:
- Reagents
- Kits
- Chip Sequencing Kit
- Whole Genomic Amplification Kit
- Bisulfite Conversion Kit
- RNA Sequencing Kit
- Others
- Instruments
- Enzymes
- Services
On the basis of the product, the market has been divided into reagents, kits (chip sequencing, whole genomic amplification, bisulfite conversion, RNA sequencing, and other kits), instruments, enzymes, and services.
Breakup By Technology:
- DNA Methylation
- Histone Methylation
- Histone Acetylation
- Large Non-Coding RNA
- MicroRNA Modification
- Chromatin Structures
Based on technology, the market has been classified into DNA methylation, histone methylation, histone acetylation, large non-coding RNA, microRNA modification, and chromatin structures.
Breakup by Application:
- Oncology
- Solid Tumors
- Liquid Tumors
- Non-Oncology
- Inflammatory Diseases
- Metabolic Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Others
On the basis of the application, the market has been bifurcated into oncology (solid and liquid tumors) and non-oncology (inflammatory, metabolic, infectious, cardiovascular, and other diseases).
Breakup By Region:
- Asia Pacific
- Europe
- North America
- Middle East and Africa
- Latin America
On a regional basis, the market has been categorized into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others), Latin America (Brazil, Mexico, and Others), and Middle East and Africa.
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
Report Scope:
| Report Features | Details |
|---|---|
| Base Year of the Analysis | 2021 |
| Historical Period | 2016-2021 |
| Forecast Period | 2022-2027 |
| Units | US$ Billion |
| Segment Coverage | Product, Technology, Application, Region |
| Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered | Abcam plc, Active Motif Inc., Agilent Technologies Inc., Diagenode Diagnostics (Hologic Inc), Illumina Inc., Merck KGaA, PerkinElmer Inc., Roche Holding AG, Thermo Fisher Scientific Inc. and Zymo Research Corporation |
| Customization Scope | 10% Free Customization |
| Report Price and Purchase Option | Single User License: US$ 2499 Five User License: US$ 3499 Corporate License: US$ 4499 |
| Post-Sale Analyst Support | 10-12 Weeks |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Read More: https://www.gettoplists.com/
